EP05.02-021 An Updated Analysis of Toripalimab and Platinum-Doublet Chemotherapy as Neoadjuvant Therapy for Potentially Resectable NSCLC

Y. Zhang, L. Zeng, X. Zhang, Y. Zhou, B. Zhang,L. Guo, W. Jiang,Y. Xiong,H. Yang, L. Liu, T. Jiang, C. Zhou, N. Yang

Journal of Thoracic Oncology（2022）

引用 0|浏览2

暂无评分

摘要

We initiated a prospective, single-arm, phase II study to explore the efficacy, safety, and feasibility of neoadjuvant toripalimab plus platinum-doublet chemotherapy in treatment-naive patients with potentially resectable non-small cell lung cancer (NSCLC). The preliminary results of the study have been presented in 2021 WCLC poster 15.02. Here we report updated data (ClinicalTrials.gov: NCT04144608).

查看译文

关键词

neoadjuvant chemotherapy,nsclc,toripalimab,platinum-doublet

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要